Literature DB >> 12559175

AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol.

Shubha Anand1, Sue Penrhyn-Lowe, Ashok R Venkitaraman.   

Abstract

The serine-threonine kinase gene AURORA-A is commonly amplified in epithelial malignancies. Here we show that elevated Aurora-A expression at levels that reflect cancer-associated gene amplification overrides the checkpoint mechanism that monitors mitotic spindle assembly, inducing resistance to the chemotherapeutic agent paclitaxel (Taxol). Cells overexpressing Aurora-A inappropriately enter anaphase despite defective spindle formation, and the persistence of Mad2 at the kinetochores, marking continued activation of the spindle assembly checkpoint. Mitosis is subsequently arrested by failure to complete cytokinesis, resulting in multinucleation. This abnormality is relieved by an inhibitory mutant of BUB1, linking the mitotic abnormalities provoked by Aurora-A overexpression to spindle checkpoint activity. Consistent with this conclusion, elevated Aurora-A expression causes resistance to apoptosis induced by Taxol in a human cancer cell line.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559175     DOI: 10.1016/s1535-6108(02)00235-0

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  213 in total

1.  Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide.

Authors:  Xi Wang; Ping Gao; Min Long; Fang Lin; Jun-Xia Wei; Ji-Hong Ren; Lin Yan; Ting He; Yuan Han; Hui-Zhong Zhang
Journal:  Med Oncol       Date:  2010-05-11       Impact factor: 3.064

2.  Myosin light chain kinase is responsible for high proliferative ability of breast cancer cells via anti-apoptosis involving p38 pathway.

Authors:  Wen-jing Cui; Yi Liu; Xiao-lei Zhou; Feng-ze Wang; Xiao-dong Zhang; Li-hong Ye
Journal:  Acta Pharmacol Sin       Date:  2010-05-10       Impact factor: 6.150

Review 3.  From gene function to improved health: genome research in the United Kingdom.

Authors:  George K Radda; Ian Viney
Journal:  J Mol Med (Berl)       Date:  2004-01-08       Impact factor: 4.599

Review 4.  The spindle checkpoint: a quality control mechanism which ensures accurate chromosome segregation.

Authors:  Stephen S Taylor; Maria I F Scott; Andrew J Holland
Journal:  Chromosome Res       Date:  2004       Impact factor: 5.239

5.  Aurora A inhibitor (MLN8237) plus vincristine plus rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma.

Authors:  Daruka Mahadevan; Amy Stejskal; Laurence S Cooke; Ann Manziello; Carla Morales; Daniel O Persky; Richard I Fisher; Thomas P Miller; Wenqing Qi
Journal:  Clin Cancer Res       Date:  2012-02-28       Impact factor: 12.531

Review 6.  Fine tuning chemotherapy to match BRCA1 status.

Authors:  Melissa Price; Alvaro N A Monteiro
Journal:  Biochem Pharmacol       Date:  2010-05-25       Impact factor: 5.858

Review 7.  Aurora kinases in head and neck cancer.

Authors:  Ranee Mehra; Ilya G Serebriiskii; Barbara Burtness; Igor Astsaturov; Erica A Golemis
Journal:  Lancet Oncol       Date:  2013-09       Impact factor: 41.316

8.  Taxane-mediated radiosensitization derives from chromosomal missegregation on tripolar mitotic spindles orchestrated by AURKA and TPX2.

Authors:  M Orth; K Unger; U Schoetz; C Belka; K Lauber
Journal:  Oncogene       Date:  2017-09-04       Impact factor: 9.867

9.  Bcl2l10, a new Tpx2 binding partner, is a master regulator of Aurora kinase A in mouse oocytes.

Authors:  Su-Yeon Lee; Eun-Young Kim; Kyeoung-Hwa Kim; Kyung-Ah Lee
Journal:  Cell Cycle       Date:  2016-10-18       Impact factor: 4.534

10.  A dominant interfering Bub1 mutant is insufficient to induce or alter thymic tumorigenesis in vivo, even in a sensitized genetic background.

Authors:  Dale O Cowley; Ginger W Muse; Terry Van Dyke
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.